Search
Kathryn Doyle, a partner at Saul Ewing, will present during the Penn Medicine Commercialization Speaker Series. She will discuss the latest trends in Life Sciences intellectual property on November 17 from 12:00 - 1:00 p.m.
THE INCENTIVIZING OF PHARMACEUTICAL INNOVATIONS IN THE BIDEN ADMINISTRATION Doreen Trujillo, a Partner in the firm's Life Sciences practice, will participate as a panelist during the 2022 Life Sciences Masters, hosted by IP Watchdog.
IP INSIGHTS: I HAVE AN INVENTION! NOW WHAT? I have an invention! I want to tell everyone, but now what? When and how do I disclose to Yale OCR, why can’t I tell the world, and when do my collaborators become co-inventors? During this IP Insights seminar, let's discuss disclosures as a whole...
Charles M. Lizza and Sarah A. Sullivan of Saul Ewing’s Newark Office secured a precedent-setting victory in a patent infringement case in the Federal District Court for the District of New Jersey involving Janssen Pharmaceuticals, Inc.’s (“J&J”) and Mitsubishi Tanabe Pharma Corp.’s (“MTPC”)...
On September 1, 2020, the Centers for Medicare & Medicaid Services (CMS) published in the Federal Register a proposed rule that, if finalized, would establish a Medicare coverage pathway to provide Medicare beneficiaries with faster access to new, innovative medical devices designated as...
On July 24, 2020, the Court of Appeals for the Federal Circuit ("Federal Circuit") in Gensetix, Inc. v. Baylor College of Medicine, No. 19-1424 (Fed. Cir. July 24, 2020)[1] issued an opinion involving the interplay between state sovereign immunity under the Eleventh Amendment[2] and required joinder...
On May 2, 2019, the U.S. Patent and Trademark Office (USPTO) issued "Examination Guide 1-19 - Examination of Marks for Cannabis and Cannabis Related Goods and Services after Enactment of the 2018 Farm Bill" (Guidance), outlining its policies for USPTO Examining Attorneys when reviewing trademark...
On October 29, 2018, a three-judge panel in New Jersey’s Superior Court held the lower court improperly expanded a confidentiality provision in a deal among four relators. The court held that the plaintiff, Joseph Piacentile, had not breached the confidentiality provision in the agreement, entitling...